$14.7M
1-10
MimiVax develops immunotherapeutic vaccines and targeted therapies to combat tumor growth and prevent recurrence, providing innovative solutions for cancer treatment.
National Rank
Share
Loading...
In United States
out of startups
Regional Rank
Share
Loading...
In North America
out of startups
City Rank
Share
2nd
In Buffalo
out of 17 startups
National Rank
Share
2,655th
In United States
out of 8871 startups
Regional Rank
Share
2,793rd
In North America
out of 9667 startups
City Rank
Share
1st
In Buffalo
out of 8 startups
National Rank
Share
1,148th
In United States
out of 3471 startups
Regional Rank
Share
1,192nd
In North America
out of 3719 startups
rankings by:
Not enough data points to display the chart.
National Ranking (undefined)
Loading...
...
Regional Ranking (undefined)
Loading...
...
Global Ranking (WorldWide)
Loading...
...
Industry Ranking (undefined)
Loading...
...
SubIndustry Ranking (undefined)
Loading...
...